HWAM
MYOV

Hennion & Walsh Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Hennion & Walsh Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-126,398
Closed -$3.41M – 805
2022
Q4 		$3.41M Sell
126,398
-141,504
-53% -$3.72M 0.21% 124
2022
Q3 		$4.81M Sell
267,902
-11,433
-4% -$183K 0.32% 71
2022
Q2 		$3.47M Sell
279,335
-129,744
-32% -$1.43M 0.22% 127
2022
Q1 		$5.45M Sell
409,079
-25,295
-6% -$339K 0.29% 88
2021
Q4 		$6.76M Buy
434,374
+9,172
+2% +$175K 0.33% 78
2021
Q3 		$9.54M Buy
425,202
+4,922
+1% +$108K 0.5% 42
2021
Q2 		$9.57M Buy
420,280
+20,950
+5% +$441K 0.51% 37
2021
Q1 		$8.22M Buy
+399,330
New +$9.09M 0.49% 36

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Hennion & Walsh Asset Management's MYOV Position: Q1 2023 in Review

Hennion & Walsh Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 126,398 shares — an estimated $3.41M sold.

Hennion & Walsh Asset Management first reported a position in MYOV in Q1 2021 and held it in 8 quarters. The position peaked at $9.57M in Q2 2021. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Hennion & Walsh Asset Management reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 126,398 Myovant Sciences Ltd. shares in Q1 2023, an estimated $3.41M.
  • Hennion & Walsh Asset Management first reported a position in Myovant Sciences Ltd. in Q1 2021 and held it in 8 quarters.
  • Hennion & Walsh Asset Management's Myovant Sciences Ltd. position peaked at $9.57M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2023, filed 20 Apr 2023.